R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
R&D Future of generative AI in pharma Talk of implementing automation and AI to enhance human capacity is dominating conversations.
R&D Why life sciences companies need to engage with Labour now Lexington senior counsel Ben Nunn discusses the opposition party leader's mission statement.
Oncology Better balance of cancer treatment efficacy and toxicity The FDA Oncology Center of Excellence announced its Project Optimus draft guidance in January.
R&D JP Morgan 2023 – Joe Spinelli Editor-in-chief Jonah Comstock chats virtually with Aranscia's Joe Spinelli.
R&D JP Morgan 2023 – Lisa Yañez At JP Morgan Week, pharmaphorum caught up with Lisa Yañez, CEO of Aerami Therapeutics.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
